Nelipepimut S companion diagnostic - Galena/Leica

Drug Profile

Nelipepimut S companion diagnostic - Galena/Leica

Alternative Names: E75 companion diagnostic - Galena/Leica; NueVax™ companion diagnostic - Galena/Leica

Latest Information Update: 12 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Galena Biopharma; Leica Biosystems
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Breast cancer

Most Recent Events

  • 05 Jun 2015 Phase-III development is ongoing in USA, Canada and Europe
  • 05 Dec 2012 Phase-III clinical trials in Breast cancer (Diagnosis) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top